Hartford Healthcare HLS Fund Class IB (HBGHX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
13.55
+0.04 (0.30%)
Jun 4, 2025, 4:00 PM EDT
-11.26% (1Y)
| Fund Assets | 350.11M |
| Expense Ratio | 1.18% |
| Min. Investment | $0.00 |
| Turnover | n/a |
| Dividend (ttm) | 0.11 |
| Dividend Yield | 0.81% |
| Dividend Growth | -54.38% |
| Payout Frequency | Annual |
| Ex-Dividend Date | Aug 23, 2024 |
| Previous Close | 13.51 |
| YTD Return | -5.85% |
| 1-Year Return | -10.93% |
| 5-Year Return | 11.17% |
| 52-Week Low | 13.03 |
| 52-Week High | 16.68 |
| Beta (5Y) | 0.67 |
| Holdings | 102 |
| Inception Date | n/a |
About HBGHX
HBGHX is a mutual fund that trades on the NASDAQ stock exchange in the United States.
Category Health
Stock Exchange NASDAQ
Ticker Symbol HBGHX
Share Class Ib
Index S&P Composite 1500 Health Care TR
Performance
HBGHX had a total return of -10.93% in the past year, including dividends. Since the fund's inception, the average annual return has been 20.25%.
Other Share Classes
These are alternative share classes of the same fund, from the same provider.
| Symbol | Share Class | Expense Ratio |
|---|---|---|
| HIAHX | Ia | 0.93% |
Top 10 Holdings
48.51% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 14.43% |
| UnitedHealth Group Incorporated | UNH | 8.59% |
| Boston Scientific Corporation | BSX | 4.91% |
| Merck & Co., Inc. | MRK | 3.80% |
| Intuitive Surgical, Inc. | ISRG | 3.60% |
| Vertex Pharmaceuticals Incorporated | VRTX | 3.41% |
| Cencora, Inc. | COR | 2.69% |
| Johnson & Johnson | JNJ | 2.45% |
| Thermo Fisher Scientific Inc. | TMO | 2.43% |
| AbbVie Inc. | ABBV | 2.21% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Aug 23, 2024 | $0.11309 | Aug 23, 2024 |
| Aug 25, 2023 | $0.24792 | Aug 25, 2023 |
| Aug 26, 2022 | $4.64694 | Aug 26, 2022 |
| Aug 27, 2021 | $2.6796 | Aug 27, 2021 |
| Aug 27, 2020 | $4.68939 | Aug 27, 2020 |
| Aug 27, 2019 | $3.22597 | Aug 27, 2019 |